Ginkgo Bioworks Holdings, Inc. (DNA)
NYSE: DNA · Real-Time Price · USD
9.61
+0.29 (3.11%)
At close: Jun 26, 2025, 4:00 PM
9.80
+0.19 (1.98%)
After-hours: Jun 26, 2025, 7:55 PM EDT
Ginkgo Bioworks Holdings Market Cap
Ginkgo Bioworks Holdings has a market cap or net worth of $562.49 million as of June 26, 2025. Its market cap has decreased by -50.22% in one year.
Market Cap
562.49M
Enterprise Value
480.13M
1-Year Change
-50.22%
Ranking
Category
Stock Price
$9.61
Market Cap Chart
Since April 19, 2021, Ginkgo Bioworks Holdings's market cap has decreased from $2.18B to $562.49M, a decrease of -74.22%. That is a compound annual growth rate of -27.65%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 26, 2025 | 562.49M | 7.91% |
| Dec 31, 2024 | 521.27M | -84.36% |
| Dec 29, 2023 | 3.33B | 16.75% |
| Dec 30, 2022 | 2.86B | -76.89% |
| Dec 31, 2021 | 12.35B | 466.18% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 714.54B |
| Johnson & Johnson | 367.31B |
| AbbVie | 329.79B |
| Novo Nordisk | 301.06B |
| UnitedHealth Group | 275.90B |
| Abbott Laboratories | 232.72B |
| Novartis AG | 231.01B |
| AstraZeneca | 216.45B |